3Christophe T,Rene K,Helene E,et al.A randomized comparison of a percutaneous suture device versus m anual compression for femoral artery hemostasis after PTCA[J].J Interven Cardio1,2003,l6(3):21 7 221.
4Kussmaul GW,Buchbinder M,Whitlow PL,et al.Rapid arterial hemostasis and decressed access site complications after cardiac catheterization and angiography:results of a randomized trial of a novel hemostatic device[J].J Am Coll Cardiol,1995,25(9):1685-1692.
5Sesana M,Vaghetti M,Albiero R,et al.Effectiveness and complications of vascular access closure devices after interventional procedures[J].J Invas Cardiol,2000,12(8):395-399.
6Daniel BB.Current status of suture-mediated closure:what is the cost of comfort[J] J Vasc Intervent Radiol,2003,14(6):677-681.
2[2]Park S,Lee DY,Won JY,et al.Extrahepatic collateral supply of hepatocellular carcinoma by the intercostal arteries[J].JVIR,2003,14(4):461-468.
3[3]Gokan T,Hashimoto T,Matsui S,et al.Helical CT demonstration of dilated right nferior phrenic arteries as extrahepatic collateral arteries of hepatocellular carcinomas[J].J Comput Assist Tomogr,2001,25(1):68-73.
4[5]Tajima T,Honda H,Kuroiwa T,et al.Pulmonary complications after hepatic artery chemoembolization or infusion via the inferior phrenic artery for primary liver cancer[J].JVIR,2002,13(9):893-900.
8Hass PC, Kracjer Z, Diethrich EB. Closure of large percutaneous access sites using the prostar XL[ J ].J Endovasc Surg, 1999,6:168-170.
9Hanlon S,Khodja RH,Proudfoot CW,et al.A Systematic literature Review of the efficacy and safety of the prostar XL device for the closure of large femoral arterial access sites in patients undergoing percutaneous endovascular aortic procedures[J]. EurJ Vase Endovase Surg,2010,10:1-14.
10Gerckens U,Attelaens N,Lame EG,et al. Management of arterial puncture site after catlleterization procedures: evaluating a sutuer- mediated closure device[J].Am J Cardiol, 1999,83:1658-1663.
